The use of dendritic cells in cancer therapy

This publication has 54 references indexed in Scilit:

• Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma
  International Journal of Cancer, 1999
• Analysis of a Chronic Myelogenous Leukemia Patient Vaccinated with Leukemic Dendritic Cells Following Autologous Peripheral Blood Stem Cell Transplantation
  Japanese Journal of Cancer Research, 1999
• Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
  Journal of Clinical Investigation, 1999
• Modulation of Proteasomal Activity Required for the Generation of a Cytotoxic T Lymphocyte–defined Peptide Derived from the Tumor Antigen MAGE-3
  The Journal of Experimental Medicine, 1999
• Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
  Nature Biotechnology, 1998
• Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells
  Human Immunology, 1997
• Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3
  International Journal of Cancer, 1995
• Proliferating dendritic cell progenitors in human blood.
  The Journal of Experimental Medicine, 1994
• Tolerance, Danger, and the Extended Family
  Annual Review of Immunology, 1994
• Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
  The Journal of Experimental Medicine, 1990